重症急性胰腺炎患者乌司他丁联合奥曲肽治疗的临床效果分析

目的:研究重症急性胰腺炎患者乌司他丁与奥曲肽联合治疗的临床效果。方法:选择2013年1月至2016年1月在我院收治的重症急性胰腺炎患者80例作为此次研究的对象,将这80例患者随机分为对照组和观察组各40例,其中对照组用奥曲肽进行治疗,观察组用乌司他丁与奥曲肽联合进行治疗,观察两组患者的治疗效果以及患者的住院时间、尿淀粉酶的变化。结果:观察组采用乌司他丁联合奥曲肽进行治疗以后,住院时间明显比对照组要少,尿淀粉酶的结果也比对照组要低。结论:重症急性胰腺炎使用乌司他丁联合奥曲肽治疗,取得的治疗效果相对较好,不但可以使患者的血尿淀粉酶达到正常,还可以减少患者的住院时间,从而减轻患者的经济压力。

Objective: to study the patients with severe acute pancreatitis ulinastatin with Mr Qu peptide clinical effect of combination therapy.Methods: between January 2013 and January 2016 in our hospital 80 cases of severe acute pancreatitis patients as the research object, the 80 patients were randomly divided into control group and observation group and control group, 40 cases of control group treated with Mr Qu peptide, observation group with ulinastatin and Mr Octreotide combined treatment, to observe the therapeutic effect of two groups of patients, and the patient’s hospital stay, the change of urine amylase.Results: observation group with ulinastatin combined the peptide after treatment, hospitalization time significantly less than the control group, the results of urine amylase also is lower than the control group.Conclusion: severe acute pancreatitis using ulinastatin combined the peptide treatment, the treatment effect is relatively good, not only can make the patient’s blood in the urine amylase to normal, also can reduce the patient’s hospital stay, so as to reduce the economic pressure of patients.